Blood disorder therapeutics firm Bioverativ, which was spun out from Biogen earlier this year, announced a research collaboration with Bicycle Therapeutics focused on developing and commercializing ...
The inhibition of pathological protein-protein interactions is a promising approach for treating a large number of diseases, including many forms of cancer. A team of researchers has now developed a ...
Chemists from Scripps Research and the University of California, Los Angeles, have developed methods for the precise, flexible modification of a broad class of chemical compounds called bicyclic ...
BERLIN & CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bayer and Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics by utilizing ...
Phase 1/2 study of the novel SUMOylation inhibitor TAK-981 in adult patients (pts) with advanced or metastatic solid tumors or relapsed/refractory (RR) hematologic malignancies. This is an ASCO ...
AstraZeneca will partner with Bicycle Therapeutics to develop respiratory, cardiovascular, and metabolic disease treatments based on Bicycle’s proprietary bicyclic peptide (Bicycle ®) product platform ...
Cytokinetics Inc. has identified bicyclic piperazinones with the ability to modulate skeletal muscle contractility reported to be useful for the treatment of amyotrophic lateral sclerosis, spinal ...
Transactions of the American Mathematical Society, Vol. 358, No. 6 (Jun., 2006), pp. 2579-2610 (32 pages) We examine some properties of bicyclic algebras, i.e. the tensor product of two cyclic ...
Consists of six departments and provides education in the fields of physics, mathematics, chemistry, informatics, biology and ecology, geography and tourism. Almost all courses of study programmes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results